Prof. Xiaojiang Li 李晓江
Chief Physician, Professor
Department of Head and Neck Surgical Oncology, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of head and neck tumors, including nasopharyngeal cancer, oral and maxillofacial tumors, thyroid tumors, and laryngeal tumors. Performs tissue defect repair using various flaps after head and neck surgery.
Dr. Li is Director of the Head and Neck Surgery Department at Yunnan Cancer Hospital. Graduating from Kunming Medical College in 1987, Dr. Li completed postgraduate studies in 2000. Training included positions at Sichuan Cancer Hospital, Cancer Hospital of the Chinese Academy of Medical Sciences, and Mahidol University. Dr. Li has published over 80 papers and received four Yunnan Province Health Science and Technology Progress Third Prizes.
Professional roles
- Member, Head and Neck Tumor Professional Committee, China Anti-Cancer Association
- Member, Southwest Region Head and Neck Surgery Collaboration Committee
- Member, Yunnan Province Otolaryngology Society
- Editorial Board Member, Chinese Journal of Otorhinolaryngology Head and Neck Surgery
Name order: in Chinese the family name comes first (Li Xiaojiang). Papers usually list the name as Xiaojiang Li or Li X.
Selected publications
32 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2025 (senior author): [Clinical characteristics and prognosis analysis of 108 cases of recurrent nasopharyngeal carcinoma from a single center]. PubMed 40744885
- Front Biosci (Landmark Ed), 2025 (senior author): Anti-ferroptosis: A Promising Therapeutic Approach in Nasopharyngeal Carcinoma. PubMed 40613277
- Infect Agent Cancer, 2025 (senior author): Tumor-infiltrating CD4(+) CD25(+) FOXP3(+) Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma. PubMed 40346620
- Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2025 (senior author): [Expression of NFAT5 and IGF1R in nasopharyngeal carcinoma tissues and analysis of clinical characteristics]. PubMed 40166875
- Braz J Otorhinolaryngol, 2025 (senior author): LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment. PubMed 39874810
- Asian J Surg, 2024 (senior author): Laryngeal sarcoma: A case report and literature review. PubMed 39019760
- Front Biosci (Landmark Ed), 2024 (senior author): Anti-Ferroptosis: A Promising Therapeutic Method for Thyroid Cancer. PubMed 38420811
- J Int Med Res, 2021 (senior author): Long non-coding (lnc)RNA profiling and the role of a key regulator lnc-PNRC2-1 in the transforming growth factor-β1-induced epithelial-mesenchymal transition of CNE1 nasopharyngeal carcinoma cells. PubMed 33752469
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion